Editorial Article
Could organ-on-a-chip models help replace animal drug testing?
As the FDA and NIH plan to phase out animal-based drug testing, organ-chip models are filling this critical gap
Through extensive research, experimentation, and clinical trials, experts in the field of drug discovery and development identify promising biopharmaceutical or pharmaceutical drug candidates, optimize their efficacy and safety profiles, and navigate regulatory processes for eventual market approval. From innovative therapies to groundbreaking treatments, this dynamic scientific field plays a pivotal role in revolutionizing medicine and saving lives.
As the FDA and NIH plan to phase out animal-based drug testing, organ-chip models are filling this critical gap